(MedPage Today) — Prescriptions for GLP-1 receptor agonists for patients with cancer have increased despite a lack of clinical guidance on the drugs’ safety and efficacy in cancer, a large retrospective review of health records showed.
Overall…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/118366
Author :
Publish date : 2025-11-07 15:06:00
Copyright for syndicated content belongs to the linked Source.
